| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |